Welcome readers, we are currently gathering a database and you will be able to enjoy PlexPage starting June 1st fully. In the meantime, please check out the web.plex.page and scholar.plex.page.

Capecitabine

Summarized by Plex Health
Last Updated: 02 May 2022
treatment of her2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the uk experience. "treatment of her2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the uk experience.", by Sutherland S, Ashley S, Miles D, Chan S, Wardley A, Davidson N, Bhatti R, Shehata M, Nouras H, Camburn T, Johnston SR. fig3: Response of CNS metastases to lapatinib and capecitabine in the absence of previous whole-brain radiotherapy. This 61-year-old woman with HER2-positive breast cancer was diagnosed in 2002. Subsequently, she received three lines of trastuzumab-containing chemotherapy...

Capecitabine is used alone or in combination chemotherapy to deal with colon cancer, breast cancer, or colon cancer. Capecitabine is also being researched in the treatment of other types of cancer. Meaning from the NCI Drug Dictionary, Detailed scientific meaning and other names for this medicine. Drugs are typically examined to figure out if they can aid treat or prevent problems besides the ones they are approved for. This patient details sheet applies only to accepted uses the drug. Much of the information might also apply to unauthorized uses that are being examined. For Metastatic HER2-Positive Breast Cancer, New Treatments Emerge Altering Chemotherapy Improves Outcomes in Early-Stage Pancreatic Cancer.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

PubChem - CovalentUnitCount

(Table source)
CIDMolecularFormulaMolecularWeightCanonicalSMILESIsomericSMILESInChIInChIKeyIUPACNameXLogPExactMassMonoisotopicMassTPSAComplexityChargeHBondDonorCountHBondAcceptorCountRotatableBondCountHeavyAtomCountIsotopeAtomCountAtomStereoCountDefinedAtomStereoCountUndefinedAtomStereoCountBondStereoCountDefinedBondStereoCountUndefinedBondStereoCountCovalentUnitCount
60953C15H22FN3O6359.35CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)OCCCCCOC(=O)NC1=NC(=O)N(C=C1F)[[email protected]]2[[email protected]@H]([[email protected]@H]([[email protected]](O2)C)O)OInChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1GAGWJHPBXLXJQN-UORFTKCHSA-Npentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate0.6359.14926359359.1492635912158203772504400001
*** If you want us to remove all links leading to your domain from Plex.page and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.

logo

Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.